trending Market Intelligence /marketintelligence/en/news-insights/trending/f6kvcabsl_y0bpwcimsizq2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

LivaNova medical implant receives US FDA clearance for treating heart condition

Blog

Needham & Company is Now Available in the S&P Global Market Intelligence Aftermarket Research Collection

Blog

Banking Essentials Newsletter - February Edition

Blog

Message in a (Word)Cloud

Six trends shaping the industries and sectors we cover in 2021


LivaNova medical implant receives US FDA clearance for treating heart condition

LivaNova PLC said the U.S. Food and Drug Administration granted 510(k) clearance to its medical implant Memo 4D, a semi-rigid ring used for treating a type of heart condition.

The London-based medical device maker said the Memo 4D is a semi-rigid mitral annuloplasty ring to treat mitral regurgitation, a disorder of the heart in which the mitral valve does not close properly when the heart pumps out blood.

Mitral valve annuloplasty is a surgical technique for the repair of leaking mitral valves.